Digital Infarction in a Patient with Raynaud's Phenomenon Associated with Treatment with a Specific Serotonin Reuptake Inhibitor-Reference-Cited by-同舟云学术

Digital Infarction in a Patient with Raynaud's Phenomenon Associated with Treatment with a Specific Serotonin Reuptake Inhibitor

Published:1996-09 Issue:9 Volume:47 Page:901-903
ISSN:0003-3197
Container-title:Angiology
language:en
Short-container-title:Angiology

Author:

Bell Caroline¹,Coupland Nicholas¹,Creamer Paul²

Affiliation:

1. Psychopharmacology Unit, Bristol University

2. Rheumatology Department, Bristol

Abstract

The authors report the worsening of preexisting Raynaud's phenomenon during treatment of depression with a selective serotonin reuptake inhibitor, fluvoxamine.

Publisher

SAGE Publications

Subject

Cardiology and Cardiovascular Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/000331979604700909

Reference11 articles.

1. Plasma free and intraplatelet serotonin in patients with Raynaud's phenomenon

2. Hypersensitivity of scleroderma cutaneous vascular smooth muscle to 5-hydroxytryptamine

3. The Effects of Platelet-Derived Contractile Agents on Human Digital Arteries

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serotonin and systemic sclerosis. An emerging player in pathogenesis;Joint Bone Spine;2022-05

2. Microvascular hand surgery for digital ischemia in scleroderma;Journal of Scleroderma and Related Disorders;2019-07-29

3. Pathophysiology and management of Raynaud's phenomenon;International Journal of Academic Medicine;2018

4. The role of platelets in autoimmunity, vasculopathy, and fibrosis: Implications for systemic sclerosis;Seminars in Arthritis and Rheumatism;2017-12

5. Chronic stress and mental disorders in patients with systemic scleroderma: Results of an interdisciplinary study;Terapevticheskii arkhiv;2017-05-15